Cargando…

The effect of COVID-19 on prostate cancer testing in Australia

AIM: The effects of the COVID-19 pandemic on healthcare in Australia have yet to be fully determined. There are well documented decreases in the rates of screening and diagnostic testing for many cancers in 2020, with commensurate stage migration of cancers when they are eventually detected. We aime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jain, Anika, Macneil, James, Kim, Lawrence, Patel, Manish I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212195/ https://www.ncbi.nlm.nih.gov/pubmed/35729543 http://dx.doi.org/10.1186/s12894-022-01043-2

Ejemplares similares

Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study
por: Yu, Xue Qin, et al.
Publicado: (2017)

An Economic Evaluation of Government-Funded COVID-19 Testing in Australia
por: Karnon, Jonathan, et al.
Publicado: (2022)

Men under the age of 55 years with screen detected prostate cancer do not have less significant disease compared to older men in a population of patients in Australia
por: Dantanarayana, Nandu D., et al.
Publicado: (2015)

Recent trends in mortality from prostate cancer in male populations of Australia and England and Wales.
por: Holman, C. D., et al.
Publicado: (1981)

Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study
por: Egger, Sam, et al.
Publicado: (2022)

Cancer Australia's Response to the COVID-19 Pandemic
por: Milch, V., et al.
Publicado: (2021)

Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020
por: Machalek, Dorothy A., et al.
Publicado: (2022)

Medications for early treatment of COVID‐19 in Australia
por: Polkinghorne, Adam, et al.
Publicado: (2022)

Work-related experiences of prostate cancer survivors in Australia: a qualitative study
por: Liu, Wei-Hong, et al.
Publicado: (2023)

Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach
por: Pathirana, Thanya, et al.
Publicado: (2019)

Penile pressure ulcers secondary to indwelling catheter and prone positioning for COVID-19 infection
por: Wang, Henry, et al.
Publicado: (2023)

Investigation of the performance of serological assays used for Lyme disease testing in Australia
por: Best, Susan J., et al.
Publicado: (2019)

EPH135 The Effect of Lockdown on Reducing Hospitalisations Associated with COVID-19 in Australia
por: Choi, S, et al.
Publicado: (2022)

Delaying the COVID‐19 epidemic in Australia: evaluating the effectiveness of international travel bans
por: Adekunle, Adeshina, et al.
Publicado: (2020)

Urban–rural prostate cancer disparities in a regional state of Australia
por: Foley, Georgea R., et al.
Publicado: (2022)

COVID-19 vaccine intentions in Australia
por: Edwards, Benjamin, et al.
Publicado: (2021)

COVID-19 vaccine intentions in Australia
por: Pickles, Kristen, et al.
Publicado: (2021)

Poor survival of females with bladder cancer is limited to those aged 70 years or over: a population-wide linkage study, New South Wales, Australia
por: Patel, Manish I, et al.
Publicado: (2015)

‘Worth the test?’ Pragmatism, pill testing and drug policy in Australia
por: Groves, Andrew
Publicado: (2018)

THRIVE: five years on and into the COVID-19 era
por: Sud, Anika, et al.
Publicado: (2021)

Prostate cancer awareness, case-finding, and early diagnosis: Interviews with undiagnosed men in Australia
por: Kannan, Ashwini, et al.
Publicado: (2019)

Disease mapping: Geographic differences in population rates of interventional treatment for prostate cancer in Australia
por: Cameron, Jessica K., et al.
Publicado: (2023)

COVID-19 Testing and Vaccine Willingness: Cross-Sectional Survey in a Culturally Diverse Community in Sydney, Australia
por: Ayre, Julie, et al.
Publicado: (2022)

Cardiac Complications in Patients Hospitalised With COVID-19 in Australia
por: Bhatia, Kunwardeep S., et al.
Publicado: (2021)

The acceptability and uptake of smartphone tracking for COVID-19 in Australia
por: Garrett, Paul M., et al.
Publicado: (2021)

Will the COVID-19 pandemic affect population ageing in Australia?
por: Wilson, Tom, et al.
Publicado: (2021)

Is COVID-19 impacting prostate cancer screening? A survey of prostate-specific antigen test requests during a local outbreak
por: Ferrari, Anna, et al.
Publicado: (2021)

COVID-19 Down Under: Australia’s Initial Pandemic Experience
por: Cook, Matthew James, et al.
Publicado: (2020)

COVID-19, individual wellbeing and multi-dimensional poverty in the state of South Australia
por: Saikia, Udoy, et al.
Publicado: (2021)

1775P Optimal cancer care in the context of COVID-19 in Australia
por: Milch, V., et al.
Publicado: (2020)

Doctors' perspectives on PSA testing illuminate established differences in prostate cancer screening rates between Australia and the UK: a qualitative study
por: Pickles, Kristen, et al.
Publicado: (2016)

Willingness to vaccinate against COVID-19 in Australia
por: Dodd, Rachael H, et al.
Publicado: (2021)

COVID-19 and psychogeriatrics: the view from Australia
por: Pachana, Nancy A., et al.
Publicado: (2020)

Intention to vaccinate against COVID-19 in Australia
por: Rhodes, Anthea, et al.
Publicado: (2021)

Impact of COVID-19 on Lung Transplantation in Australia
por: Johal, M.S., et al.
Publicado: (2021)

Preferences for a COVID-19 vaccine in Australia
por: Borriello, Antonio, et al.
Publicado: (2021)

Men’s perceptions of prostate cancer diagnosis and care: insights from qualitative interviews in Victoria, Australia
por: Kirkman, Maggie, et al.
Publicado: (2017)

COVID-19 and mental health in Australia – a scoping review
por: Zhao, Yixuan, et al.
Publicado: (2022)

(662) Heart and Lung Transplant Unit - Western Australia Covid-19 Experience
por: House, C., et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia
por: Song, Rachel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_evvv2drj27c6u550doladt828a